According to Cooper Companies's latest financial reports the company has $0.13 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-10-31 | $0.12 B | -12.59% |
2022-10-31 | $0.13 B | 44.11% |
2021-10-31 | $95.9 M | -17.26% |
2020-10-31 | $0.11 B | 30.22% |
2019-10-31 | $89 M | 14.54% |
2018-10-31 | $77.7 M | -12.5% |
2017-10-31 | $88.8 M | -11.9% |
2016-10-31 | $0.10 B | 513.66% |
2015-10-31 | $16.42 M | -34.87% |
2014-10-31 | $25.22 M | -67.41% |
2013-10-31 | $77.39 M | 502.75% |
2012-10-31 | $12.84 M | 148.12% |
2011-10-31 | $5.17 M | 44.84% |
2010-10-31 | $3.57 M | -9.13% |
2009-10-31 | $3.93 M | 102.26% |
2008-10-31 | $1.94 M | -39.74% |
2007-10-31 | $3.22 M | -60.77% |
2006-10-31 | $8.22 M | -73.32% |
2005-10-31 | $30.82 M | -25.17% |
2004-10-31 | $41.19 M | -22.53% |
2003-10-31 | $53.17 M | 308.91% |
2002-10-31 | $13 M | -37.8% |
2001-10-31 | $20.91 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $22.92 B | 16,857.84% | ๐บ๐ธ USA |
Novartis NVS | $13.96 B | 10,226.92% | ๐จ๐ญ Switzerland |
Boston Scientific BSX | $0.86 B | 539.79% | ๐บ๐ธ USA |
Teleflex TFX | $0.22 B | 64.83% | ๐บ๐ธ USA |
Utah Medical Products UTMD | $88.2 M | -34.76% | ๐บ๐ธ USA |
Atrion ATRI | $6.25 M | -95.37% | ๐บ๐ธ USA |